New Key Statistics Module, Z-Score and F-Score
WBO:BMED Key Ratios
| Market Cap € M | 8,959.14 |
| Enterprise Value € M | 8,897.84 |
| P/E(ttm) | 9.81 |
| PE Ratio without NRI | 9.30 |
| Forward PE Ratio | 10.23 |
| Price/Book | 2.31 |
| Price/Sales | 4.23 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | 0.54 |
| Revenue (TTM) € M | 2,141.00 |
| EPS (TTM) € | 1.24 |
| Beneish M-Score | -1.97 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -- |
| EV-to-EBITDA | -- |
| PEG | 0.96 |
| Shares Outstanding M | 737.38 |
| Net Margin (%) | 43.15 |
| Operating Margin % | -- |
| Pre-tax Margin (%) | 56.51 |
| Quick Ratio | -- |
| Current Ratio | -- |
| ROA % (ttm) | 1.16 |
| ROE % (ttm) | 25.45 |
| ROIC % (ttm) | -- |
| Dividend Yield % | 6.46 |
| Altman Z-Score | -- |
WBO:BMED Number of Guru Trades
WBO:BMED Volume of Guru Trades
Gurus Latest Trades with WBO:BMED
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
WBO:BMED is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers